Dermazin, 50 g, Sandoz

What Dermazin is and what it is used for

Dermazin contains the active substance silver sulfadiazine. It works by killing bacteria or stopping their growth. Dermazin is mainly indicated for the treatment and prevention of infections caused by burns in burn patients.

Dermazin is also intended for the treatment and prevention of infections in pressure ulcers, varicose ulcers, abrasions, minor traumatic wounds, in incisions and other clean wounds on areas where skin grafts have been taken.

How to use Dermazin

Always use Dermazin exactly as your doctor has told you. You should talk to your doctor or pharmacist if you are not sure.

Dermazin is for cutaneous (topical) use only. Before application, clean and remove dead tissue.

Then apply Dermazin in a thin layer 2-4 mm thick; It is preferable to apply the cream to a sterile bandage, which you then place on the lesion.

The cream is applied once a day, with a sterile spatula or disposable gloves. In general, the cream should be reapplied every 24 hours. Before each application of the cream, the lesion is washed under a jet of antiseptic solution or water to remove cream residues and the exudate, which looks like pus in color but is actually aseptic, which appears abundantly after applying Dermazin.

Dermazin tubes are intended for repeated application for a single patient (the contents of one tube should be used by only one person). Applying the cream is not painful. Dermazin does not stain clothes and bed linen.

If you use more Dermazin than you should
Overdose is unlikely if used as recommended. Do not use the medicine for a longer period than recommended by your doctor.

If you forget to use Dermazin
If you forget to apply the treatment, contact your doctor as soon as possible. Do not use a double dose to make up for a forgotten dose.

If you have any further questions on this product, ask your doctor or pharmacist.

Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Life-threatening skin rashes (Stevens-Johnson syndrome, toxic epidermal necrolysis) have been reported very rarely.

Uncommon (affects less than 1 in 100 users): decrease in the number of white blood cells responsible for defending against infections (leukopenia).

Not known (frequency cannot be estimated from the available data): increase in serum osmolarity; hypersensitivity; allergic reactions such as rash, itching, contact dermatitis; gray discoloration of the skin under the influence of sunlight; burning sensation or pain.

Systemic absorption of silver sulfadiazine may very rarely cause adverse reactions associated with systemic sulfonamide therapy.

Presentation: tube with 50 g cream